Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$2.65 - $3.92 $76,497 - $113,158
28,867 New
28,867 $89,000
Q4 2022

Feb 14, 2023

BUY
$4.26 - $6.84 $186,375 - $299,250
43,750 Added 14.13%
353,383 $1.65 Million
Q3 2022

Nov 14, 2022

BUY
$6.06 - $12.86 $213,499 - $453,070
35,231 Added 12.84%
309,633 $1.88 Million
Q2 2022

Aug 15, 2022

BUY
$8.35 - $21.89 $1.02 Million - $2.68 Million
122,595 Added 80.76%
274,402 $2.87 Million
Q1 2022

May 16, 2022

SELL
$16.97 - $31.93 $9.54 Million - $17.9 Million
-562,016 Reduced 78.73%
151,807 $3.13 Million
Q4 2021

Feb 14, 2022

BUY
$25.61 - $41.78 $16.2 Million - $26.5 Million
634,285 Added 797.46%
713,823 $22.3 Million
Q3 2021

Nov 15, 2021

BUY
$19.65 - $27.99 $909,637 - $1.3 Million
46,292 Added 139.24%
79,538 $1.85 Million
Q2 2021

Aug 13, 2021

BUY
$17.48 - $25.46 $581,140 - $846,443
33,246 New
33,246 $753,000
Q1 2020

May 15, 2020

SELL
$8.78 - $18.6 $605,126 - $1.28 Million
-68,921 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$13.12 - $17.06 $904,243 - $1.18 Million
68,921 New
68,921 $1.1 Million
Q2 2019

Aug 14, 2019

SELL
$17.0 - $21.88 $378,454 - $487,092
-22,262 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$15.53 - $22.15 $345,728 - $493,103
22,262 New
22,262 $457,000

Others Institutions Holding CDXS

About CODEXIS, INC.


  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $335M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.